CoinWorld News, recently, Whale increased its holdings of 2.31 million AI16ZTokens in just three days, with a purchase price of $0.83 per token, showing strong market interest in the Token. Currently, Whale holds about 10.02 million AI16ZTokens, with a market capitalization close to $9.12 million. In addition to the dynamics of market trading, AI16Z’s progress in promoting the integration of artificial intelligence and blockchain technology is also worth following. On January 19, AI16Z reached a strategic cooperation with Stanford University and TheTree to jointly promote the application of AI Agent technology in the fields of medicine and biology, especially by optimizing research and data processing efficiency in these fields through blockchain. In addition, AI16Z and Injective jointly held a global AI Agent Hackathon, attracting developers from around the world to participate. Through this event, AI16Z not only promoted innovation in AI technology based on blockchain but also further verified its technical leadership in the field of combining AI and blockchain. These measures not only demonstrate the flow of funds and investment strategy of AI16Z in the market but also reflect its continuous efforts in promoting the depth integration of blockchain and AI technology.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
AI16Z receives increased holding from Whale, and collaborates with Stanford University and Injective to promote the application of AIAgent technology
CoinWorld News, recently, Whale increased its holdings of 2.31 million AI16ZTokens in just three days, with a purchase price of $0.83 per token, showing strong market interest in the Token. Currently, Whale holds about 10.02 million AI16ZTokens, with a market capitalization close to $9.12 million. In addition to the dynamics of market trading, AI16Z’s progress in promoting the integration of artificial intelligence and blockchain technology is also worth following. On January 19, AI16Z reached a strategic cooperation with Stanford University and TheTree to jointly promote the application of AI Agent technology in the fields of medicine and biology, especially by optimizing research and data processing efficiency in these fields through blockchain. In addition, AI16Z and Injective jointly held a global AI Agent Hackathon, attracting developers from around the world to participate. Through this event, AI16Z not only promoted innovation in AI technology based on blockchain but also further verified its technical leadership in the field of combining AI and blockchain. These measures not only demonstrate the flow of funds and investment strategy of AI16Z in the market but also reflect its continuous efforts in promoting the depth integration of blockchain and AI technology.